Table 1 Global prevalence, incidence, and YLD across countries and age-standardized rates for both sexes, females, and males, in 1990 and 2017 (with 95% uncertainty interval (UI))
Prevalence | Incidence | DALYs (YLD) | ||||
|---|---|---|---|---|---|---|
Cases (million) | Rate (per 100,000) | Cases (million) | Rate (per 100,000) | YLD (million) | Rate (per 100,000) | |
1990 | ||||||
Both | 386 (343 to 434) | 8341.1 (7389.8 to 9370.1) | 149 (131 to169) | 3168.9 (2799.7 to 3572.9) | 43 (31 to 58) | 932.5 (658.5 to 1248.3) |
Female | 224 (199 to 253) | 9528.3 (8455.2 to 10736.5) | 85 (75 to 96) | 3550.6 (3141.5 to 4008.1) | 25 (33 to 18) | 1059 (748.5 to 1414.0) |
Male | 161 (143 to 181) | 7085.9 (6299.5 to 7939.4) | 64 (56 to 73) | 2770.2 (2447.1 to 3131.8) | 18 (13 to 24) | 799.3 (562.0 to 1069.5) |
2017 | ||||||
Both | 552 (491 to 621) | 7013.7 (6247.9 to 7891.9) | 216 (191 to 244) | 2748.9 (2428.7 to 3101.6) | 62 (43 to 83) | 785.1 (554.3 to 1051.5) |
Female | 320 (285 to 360) | 7949.9 (7084 to 8961.1) | 124 (110 to 139) | 3086.9 (2735.7 to 3476.8) | 35(25 to 48) | 884.4 (626.1 to 1184.2) |
Male | 232 (206 to 260) | 6022.4 (5362.9 to 6727.9) | 92 (81 to 105) | 2392.94 (2109.3 to 2703.9) | 26 (18 to 35) | 680.3 (478.9 to 909.9) |